Meet our STaR and CSA Award Winners

PUSHING the frontiers of translational research has brought recognition to researchers from NUHS.

• Prof Daniel G Tenen, Director of the newly established Cancer Research Centre of Excellence at NUS and Prof Wong Tien Yin, Singapore Eye Research Institute received the Singapore Translational Research Investigator award.
  
  
• Assoc Prof Aung Tin, Assoc Prof Allen Yeoh Eng Juh and Assoc Prof Chng Wee Joo received the Clinician Scientist Award.
  
  Read more.

Cancer Research Centre of Excellence at NUS

The Cancer Research Centre of Excellence (RCE) at the National University of Singapore (NUS) will conduct a multifaceted and coordinated approach to cancer research, extending from basic cancer studies all the way to experimental therapeutics. The vision is to make the Cancer RCE one of the top cancer research centres in the world, with highly interrelated programmes leading to an integrated approach to better understand and treat cancer.

Established with a total funding of about $170 million from the National Research Foundation and the Ministry of Education over a period of 7 years, the Cancer RCE will focus on 5 key areas - cancer stem cells, cancer biology, cancer epigenetics, cancer genomics and experimental therapeutics. Although the Cancer RCE will focus on cancers endemic to Asian populations such as gastric, colorectal, leukaemia and breast cancers, the insights gleaned will be applicable to cancers around the world, thereby providing an opportunity for Singapore to be a world leader in cancer biology and treatment.

In addition, the Cancer RCE will play a critical role in linking NUS, the National University Hospital (NUH), the National Cancer Centre (NCC), the Genome Institute of Singapore (GIS), the Institute of Molecular & Cell Biology (IMCB), the Experimental Therapeutics Centre (ETC), the Johns Hopkins Singapore International Medical Centre, Duke-NUS Graduate Medical School and the Ludwig Institute of Cancer Research (LICR). The RCE will also provide a significant role in education at the NUS.

Master of Clinical Investigation (MCI)

The Master of Clinical Investigation (MCI) program is the latest Masters program launched by the Yong Loo Lin School of Medicine, Division of Graduate Medical Studies. It is supported by the National Research Foundation, which provides scholarships so that medical specialists in training with the Ministry of Health, and who have aptitude for and interest in clinical research, can pursue a higher degree in this area.

This program is structured to equip clinicians with the analytical knowledge and skills necessary to design and conduct investigations that are relevant to patient care.

Development of Biomedical Ethics in Singapore

The Centre of Biomedical Ethics (CBmE) has been awarded a grant of S$4.6 million for Capacity Development in Biomedical Ethics in Singapore by the National Research Foundation (NRF). The grant will fund several key initiatives, including public education in Biomedical Ethics for schools and junior colleges.